EUVIMEDEUVIMED entdecken
Open Access

Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds

Sanchita Ghosh, Sourav Patra, Muhsin H Younis, Avik Chakraborty, Apurav Guleria, Santosh K Gupta, Khajan Singh, Sutapa Rakhshit, Sudipta Chakraborty, Weibo Cai iD, Rubel Chakravarty

European Journal of Nuclear Medicine and Molecular Imaging · 2024-05 · 51 (6) · 1558-1573

DOI: 10.1007/s00259-024-06612-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 25.01.2024. Verfasst von Sanchita Ghosh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India. Hauptthemen laut MEDLINE: Brachytherapy, Ytterbium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Bhabha Atomic Research Centre, Office of Extramural Research, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Classical brachytherapy of solid malignant tumors is an invasive procedure which often results in an uneven dose distribution, while requiring surgical removal of sealed radioactive seed sources after a certain period of time. To circumvent these issues, we report the synthesis of intrinsically radiolabeled and gum Arabic glycoprotein functionalized [169Yb]Yb2O3 nanoseeds as a novel nanoscale brachytherapy agent, which could directly be administered via intratumoral injection for tumor therapy. METHODS: 169Yb (T½ = 32 days) was produced by neutron irradiation of enriched (15.2% in 168Yb) Yb2O3 target in a nuclear reactor, radiochemically converted to [169Yb]YbCl3 and used for nanoparticle (NP) synthesis. Intrinsically radiolabeled NP were synthesized by controlled hydrolysis of Yb3+ ions in gum Arabic glycoprotein medium. In vivo SPECT/CT imaging, autoradiography, and biodistribution studies were performed after intratumoral injection of radiolabeled NP in B16F10 tumor bearing C57BL/6 mice. Systematic tumor regression studies and histopathological analyses were performed to demonstrate therapeutic efficacy in the same mice model. RESULTS: The nanoformulation was a clear solution having high colloidal and radiochemical stability. Uniform distribution and retention of the radiolabeled nanoformulation in the tumor mass were observed via SPECT/CT imaging and autoradiography studies. In a tumor regression study, tumor growth was significantly arrested with different doses of radiolabeled NP compared to the control and the best treatment effect was observed with ~ 27.8 MBq dose. In histopathological analysis, loss of mitotic cells was apparent in tumor tissue of treated groups, whereas no significant damage in kidney, lungs, and liver tissue morphology was observed. CONCLUSIONS: These results hold promise for nanoscale brachytherapy to become a clinically practical treatment modality for unresectable solid cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyYtterbiumAnimalsMiceTissue DistributionNanoparticlesIsotope LabelingSingle Photon Emission Computed Tomography Computed TomographyMice, Inbred C57BLGum ArabicFemaleGlycoproteinsCell Line, TumorRadioisotopes

Stichwörter der Autor:innen

CancerIntratumoral injectionNanoscale brachytherapyRadiolabeled nanoparticlesSPECTTheranosticsTumor regression

Substanzen

YtterbiumGum ArabicGlycoproteinsRadioisotopes

Autor:innen und Institutionen

  • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.
  • Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
  • Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, USA.
  • Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai, 400012, India.
  • Radiation and Photochemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.
  • Radiochemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.

ORCID-Profile: Weibo Cai

Förderung

  • NCI NIH HHS
  • Bhabha Atomic Research Centre
  • Office of Extramural Research, National Institutes of Health

Zitieren

APA

Ghosh, S., Patra, S., Younis, M. H., Chakraborty, A., Guleria, A., Gupta, S. K., Singh, K., Rakhshit, S., Chakraborty, S., Cai, W., & Chakravarty, R. (2024). Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds. European Journal of Nuclear Medicine and Molecular Imaging, 51(6), 1558-1573. https://doi.org/10.1007/s00259-024-06612-1

Vancouver

Ghosh S, Patra S, Younis MH, Chakraborty A, Guleria A, Gupta SK, et al. Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(6):1558-1573. doi:10.1007/s00259-024-06612-1

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Sanchita and Patra, Sourav and Younis, Muhsin H and Chakraborty, Avik and Guleria, Apurav and Gupta, Santosh K and Singh, Khajan and Rakhshit, Sutapa and Chakraborty, Sudipta and Cai, Weibo and Chakravarty, Rubel},
  title = {Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {51},
  number = {6},
  pages = {1558--1573},
  doi = {10.1007/s00259-024-06612-1}
}
Kostenlos starten →